ImmunityBio (IBRX) Other Working Capital Changes (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Other Working Capital Changes of $16000.0 for Q1 2026, down 93.42% year-over-year from $243000.0 in Q1 2025, and down 80.49% quarter-over-quarter from $82000.0 in Q4 2025.
ImmunityBio (IBRX) Other Working Capital Changes (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Other Working Capital Changes for 8 consecutive years, with $16000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 93.42% year-over-year to $16000.0; the TTM figure through Mar 2026 stood at $376000.0 (up 35.25% YoY), while the FY2025 annual figure was $570000.0, up 422.94% from the prior year.
- Other Working Capital Changes retreated to $16000.0 in Q1 2026 per IBRX's latest filing, from $82000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $14.3 million in Q2 2022 and bottomed at -$11.6 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged $747117.6 across 5 years, with a median of $1.3 million in 2026.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes sank 118.41% — and 2025, when it jumped 11328.57%.
- ImmunityBio's Other Working Capital Changes stood at $2.6 million in 2022, then tumbled by 92.19% to $201000.0 in 2023, then plunged by 118.41% to -$37000.0 in 2024, then jumped by 321.62% to $82000.0 in 2025, then sank by 80.49% to $16000.0 in 2026.
- Business Quant data shows IBRX's Other Working Capital Changes at $16000.0 in Q1 2026, $82000.0 in Q4 2025, and $35000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -866,000.00 |
| Jun 30, 2026 | -866,000.00 |
| Jun 30, 2026 | -866,000.00 |
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -11.61 Mn |
| Dec 31, 2025 | -11.61 Mn |
| Dec 31, 2025 | -11.61 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Jun 30, 2025 | 4.78 Mn |
| Mar 31, 2025 | -951,000.00 |
| Mar 31, 2025 | -951,000.00 |
| Mar 31, 2025 | -951,000.00 |
| Dec 31, 2024 | 1.66 Mn |
| Dec 31, 2024 | 1.66 Mn |